Vol. 2 No. 3 (2023): JESM 2023 #3 (Vol.2)

Articles

• THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (USA) entirely dedicated to health sciences and life sciences

  A.K. Shadmanov, A.O. Okhunov

  2-14

  • PDF

• PHARMACODYNAMIC SUBSTANTIATED APPROACHES TO THE CHOICE OF ANTIMICROBIAL THERAPY FOR NOSOCOMIAL AND NON-NOSOCOMIAL PNEUMONIA

  S.S. Atakov

  15-23

  • PDF

• THE ROLE AND PLACE OF SULFATED GLYCOSAMINOGLYCANS IN THE TREATMENT OF PHLEGMON, ODONTOGENIC ORIGIN

  Sh. Abdullaev, A.S. Babakhodjaev , Q.Kh. Boboyev

  24-31

  • PDF

• CLINICAL AND MORPHOLOGICAL SUBSTANTIATION OF THE CHOICE OF TREATMENT METHOD FOR DIABETIC FOOT SYNDROME

  F.M. Abdurakhmanov

  32-43

  • PDF

• GENERAL AND BEHAVIORAL TOXICOLOGICAL EFFECTS OF SUBCHRONIC INORGANIC ARSENIC AND FLUORIDE TREATMENT IN ADULT WISTAR RATS

  K. Sarkozi, Z. Mate, T. Vezer

  44-49

  • PDF

• MICROBIOLOGICAL SUBSTANTIATION OF THE CHOICE OF PHARMACOLOGICAL GROUPS OF ANTIBACTERIAL DRUGS IN THE TREATMENT OF ABDOMINAL SEPSIS AGAINST THE BACKGROUND OF DIABETES MELLITUS

  D.N. Korikhonov

  50-57

  • PDF

• SURVIVAL TO EARLY TOXIC COPPER EXCESS BIOCHEMICAL AND ANATOMICAL CHANGES DURING GERMINATION OF INDIAN MUSTARD

  R. Szollosi, E. Kalman, I.Sz. Varga

  58-63

  • PDF

• THE CONCEPT OF MODERN NOSOCOMIAL INFECTION FROM THE STANDPOINT OF A RATIONAL APPROACH TO ANTIMICROBIAL PHARMACOTHERAPY

  N.Sh. Khudaybergenova

  64-72

  • PDF

• A REVIEW ON GLIMEPIRIDE VS TENELIGLIPTIN AS A SECOND-LINE DRUG FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS

  K. Karthickeyan, A.F. Saara, K. Gopal, S. Karthick, A.N. Ashi

  73-79

  • PDF

• THE SIGNIFICANT FACTORS OF EMPLOYEES WORK STRESS IN THE PHARMACEUTICAL INDUSTRY

  J. Kumar, S. Lakshmi

  80-85

  • PDF

• HEMODYNAMIC STATUS AND EFFICACY OF THE DRUG "EDARAVON" IN ACUTE AND CHRONIC DISORDERS OF CEREBRAL CIRCULATION

  Yu.A. Musaeva

  86-91

  • PDF

• HEALTH STATE AND ACTUAL NUTRITION OF PRESCHOOL CHILDREN

  F.I. Salomova, Sh.Kh. Bakieva, N.F. Yarmukhamedova, A.F. Dusmukhamedova

  92-101

  • PDF

• WHAT HAS CHANGED IN THE PERCEPTION OF SEPSIS OVER THE PAST 30 YEARS?

  A.R. Bobobekov

  102-108

  • PDF

• THE RATIONALE FOR THE CHOICE OF ANTISEPTICS IN THE TREATMENT OF OSTEOARTICULAR PURULENT INFECTION

  A.O. Okhunov

  109-112

  • PDF

• NEW APPROACHES IN THE TREATMENT OF TROPHIC ULCERS OF VENOUS ETIOLOGY

  S.S. Atakov

  113-119

  • PDF

• ABDOMINAL SEPSIS problems that need to be addressed

  B.Z. Hamdamov, I.E. Hotamov, A.B. Hamdamov

  120-130

  • PDF